Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Leuprolide Acetate Market Report 2017

  • QYR2175223
  • 103 Pages
  • October 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Leuprolide Acetate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Leuprolide Acetate in these regions, from 2012 to 2022 (forecast).

United States Leuprolide Acetate market competition by top manufacturers/players, with Leuprolide Acetate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

TOLMAR

Varian Pharmed

Bachem

Takeda

Sun Pharmaceutical

Livzon

Beijing Biote

Soho-Yiming

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Intramuscular Injection

Subcutaneous Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Leuprolide Acetate for each application, including

Hospitals

Clinics

Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Leuprolide Acetate Market Report 2017

1 Leuprolide Acetate Overview

1.1 Product Overview and Scope of Leuprolide Acetate

1.2 Classification of Leuprolide Acetate by Product Category

1.2.1 United States Leuprolide Acetate Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Leuprolide Acetate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Intramuscular Injection

1.2.4 Subcutaneous Injection

1.3 United States Leuprolide Acetate Market by Application/End Users

1.3.1 United States Leuprolide Acetate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 United States Leuprolide Acetate Market by Region

1.4.1 United States Leuprolide Acetate Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Leuprolide Acetate Status and Prospect (2012-2022)

1.4.3 Southwest Leuprolide Acetate Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Leuprolide Acetate Status and Prospect (2012-2022)

1.4.5 New England Leuprolide Acetate Status and Prospect (2012-2022)

1.4.6 The South Leuprolide Acetate Status and Prospect (2012-2022)

1.4.7 The Midwest Leuprolide Acetate Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Leuprolide Acetate (2012-2022)

1.5.1 United States Leuprolide Acetate Sales and Growth Rate (2012-2022)

1.5.2 United States Leuprolide Acetate Revenue and Growth Rate (2012-2022)

2 United States Leuprolide Acetate Market Competition by Players/Suppliers

2.1 United States Leuprolide Acetate Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Leuprolide Acetate Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Leuprolide Acetate Average Price by Players/Suppliers (2012-2017)

2.4 United States Leuprolide Acetate Market Competitive Situation and Trends

2.4.1 United States Leuprolide Acetate Market Concentration Rate

2.4.2 United States Leuprolide Acetate Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Leuprolide Acetate Manufacturing Base Distribution, Sales Area, Product Type

3 United States Leuprolide Acetate Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Leuprolide Acetate Sales and Market Share by Region (2012-2017)

3.2 United States Leuprolide Acetate Revenue and Market Share by Region (2012-2017)

3.3 United States Leuprolide Acetate Price by Region (2012-2017)

4 United States Leuprolide Acetate Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Leuprolide Acetate Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Leuprolide Acetate Revenue and Market Share by Type (2012-2017)

4.3 United States Leuprolide Acetate Price by Type (2012-2017)

4.4 United States Leuprolide Acetate Sales Growth Rate by Type (2012-2017)

5 United States Leuprolide Acetate Sales (Volume) by Application (2012-2017)

5.1 United States Leuprolide Acetate Sales and Market Share by Application (2012-2017)

5.2 United States Leuprolide Acetate Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Leuprolide Acetate Players/Suppliers Profiles and Sales Data

6.1 TOLMAR

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Leuprolide Acetate Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 TOLMAR Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Varian Pharmed

6.2.2 Leuprolide Acetate Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Varian Pharmed Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Bachem

6.3.2 Leuprolide Acetate Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Bachem Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Takeda

6.4.2 Leuprolide Acetate Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Takeda Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Sun Pharmaceutical

6.5.2 Leuprolide Acetate Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Sun Pharmaceutical Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Livzon

6.6.2 Leuprolide Acetate Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Livzon Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Beijing Biote

6.7.2 Leuprolide Acetate Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Beijing Biote Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Soho-Yiming

6.8.2 Leuprolide Acetate Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Soho-Yiming Leuprolide Acetate Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Leuprolide Acetate Manufacturing Cost Analysis

7.1 Leuprolide Acetate Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Leuprolide Acetate

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Leuprolide Acetate Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Leuprolide Acetate Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Leuprolide Acetate Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Leuprolide Acetate Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Leuprolide Acetate Sales Volume Forecast by Type (2017-2022)

11.3 United States Leuprolide Acetate Sales Volume Forecast by Application (2017-2022)

11.4 United States Leuprolide Acetate Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Leuprolide Acetate

Figure United States Leuprolide Acetate Market Size (K Pcs) by Type (2012-2022)

Figure United States Leuprolide Acetate Sales Volume Market Share by Type (Product Category) in 2016

Figure Intramuscular Injection Product Picture

Figure Subcutaneous Injection Product Picture

Figure United States Leuprolide Acetate Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Leuprolide Acetate by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Leuprolide Acetate Market Size (Million USD) by Region (2012-2022)

Figure The West Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Leuprolide Acetate Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Leuprolide Acetate Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Leuprolide Acetate Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Leuprolide Acetate Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Leuprolide Acetate Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Leuprolide Acetate Sales Share by Players/Suppliers

Figure 2017 United States Leuprolide Acetate Sales Share by Players/Suppliers

Figure United States Leuprolide Acetate Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Leuprolide Acetate Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Leuprolide Acetate Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Leuprolide Acetate Revenue Share by Players/Suppliers

Figure 2017 United States Leuprolide Acetate Revenue Share by Players/Suppliers

Table United States Market Leuprolide Acetate Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Leuprolide Acetate Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Leuprolide Acetate Market Share of Top 3 Players/Suppliers

Figure United States Leuprolide Acetate Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Leuprolide Acetate Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Leuprolide Acetate Product Category

Table United States Leuprolide Acetate Sales (K Pcs) by Region (2012-2017)

Table United States Leuprolide Acetate Sales Share by Region (2012-2017)

Figure United States Leuprolide Acetate Sales Share by Region (2012-2017)

Figure United States Leuprolide Acetate Sales Market Share by Region in 2016

Table United States Leuprolide Acetate Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Leuprolide Acetate Revenue Share by Region (2012-2017)

Figure United States Leuprolide Acetate Revenue Market Share by Region (2012-2017)

Figure United States Leuprolide Acetate Revenue Market Share by Region in 2016

Table United States Leuprolide Acetate Price (USD/Pcs) by Region (2012-2017)

Table United States Leuprolide Acetate Sales (K Pcs) by Type (2012-2017)

Table United States Leuprolide Acetate Sales Share by Type (2012-2017)

Figure United States Leuprolide Acetate Sales Share by Type (2012-2017)

Figure United States Leuprolide Acetate Sales Market Share by Type in 2016

Table United States Leuprolide Acetate Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Leuprolide Acetate Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Leuprolide Acetate by Type (2012-2017)

Figure Revenue Market Share of Leuprolide Acetate by Type in 2016

Table United States Leuprolide Acetate Price (USD/Pcs) by Types (2012-2017)

Figure United States Leuprolide Acetate Sales Growth Rate by Type (2012-2017)

Table United States Leuprolide Acetate Sales (K Pcs) by Application (2012-2017)

Table United States Leuprolide Acetate Sales Market Share by Application (2012-2017)

Figure United States Leuprolide Acetate Sales Market Share by Application (2012-2017)

Figure United States Leuprolide Acetate Sales Market Share by Application in 2016

Table United States Leuprolide Acetate Sales Growth Rate by Application (2012-2017)

Figure United States Leuprolide Acetate Sales Growth Rate by Application (2012-2017)

Table TOLMAR Basic Information List

Table TOLMAR Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure TOLMAR Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure TOLMAR Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure TOLMAR Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Varian Pharmed Basic Information List

Table Varian Pharmed Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Varian Pharmed Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Varian Pharmed Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Varian Pharmed Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Bachem Basic Information List

Table Bachem Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bachem Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Bachem Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Bachem Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Takeda Basic Information List

Table Takeda Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Takeda Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Takeda Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Takeda Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Sun Pharmaceutical Basic Information List

Table Sun Pharmaceutical Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sun Pharmaceutical Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Sun Pharmaceutical Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Sun Pharmaceutical Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Livzon Basic Information List

Table Livzon Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Livzon Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Livzon Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Livzon Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Beijing Biote Basic Information List

Table Beijing Biote Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Beijing Biote Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Beijing Biote Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Beijing Biote Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Soho-Yiming Basic Information List

Table Soho-Yiming Leuprolide Acetate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Soho-Yiming Leuprolide Acetate Sales Growth Rate (2012-2017)

Figure Soho-Yiming Leuprolide Acetate Sales Market Share in United States (2012-2017)

Figure Soho-Yiming Leuprolide Acetate Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Leuprolide Acetate

Figure Manufacturing Process Analysis of Leuprolide Acetate

Figure Leuprolide Acetate Industrial Chain Analysis

Table Raw Materials Sources of Leuprolide Acetate Major Players/Suppliers in 2016

Table Major Buyers of Leuprolide Acetate

Table Distributors/Traders List

Figure United States Leuprolide Acetate Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Leuprolide Acetate Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Leuprolide Acetate Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Leuprolide Acetate Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Leuprolide Acetate Sales Volume Share Forecast by Region (2017-2022)

Figure United States Leuprolide Acetate Sales Volume Share Forecast by Region (2017-2022)

Figure United States Leuprolide Acetate Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370